LHDX Lucira Health, Inc.

Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It has developed a testing platform that produces COVID-19 single-use test kit with molecular accuracy. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was founded in 2013 and is headquartered in Emeryville, California.

As of 10/15/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  02/04/2021
Outstanding shares:  38,698,789
Average volume:  220,102
Market cap:   $219,809,122
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    54948U105
ISIN:        US54948U1051
Valuation   (See tab for details)
PE ratio:   -4.74
PB ratio:   1.03
PS ratio:   12.76
Return on equity:   -27.11%
Net income %:   -339.72%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy